Clinical Trial Update: Stem Cell Therapy as Adjunct to Revascularization [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of stem cell therapy as an adjunct to revascularization was withdrawn. The study involved coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Coronary Arteriosclerosis, Coronary Artery Bypass Graft | Phase 1 | Status: WITHDRAWN